COVID-19 and venous thromboembolism: current insights and prophylactic strategies.
作者信息
Ambrosino Pasquale, Di Minno Alessandro, Maniscalco Mauro, Di Minno Matteo Nicola Dario
机构信息
Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Department of Pharmacy, Federico II University, Naples, Italy.
出版信息
Ann Med. 2020 Sep;52(6):239-242. doi: 10.1080/07853890.2020.1791355. Epub 2020 Jul 13.
Abstract
摘要
相似文献
1
COVID-19 and venous thromboembolism: current insights and prophylactic strategies.2019冠状病毒病与静脉血栓栓塞症：当前见解与预防策略
Ann Med. 2020 Sep;52(6):239-242. doi: 10.1080/07853890.2020.1791355. Epub 2020 Jul 13.
2
Venous thromboembolism and COVID-19.静脉血栓栓塞与2019冠状病毒病
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
3
Venous Thromboembolism and Heparin Use in COVID-19 Patients: Juggling between Pragmatic Choices, Suggestions of Medical Societies and the Lack of Guidelines.2019冠状病毒病患者的静脉血栓栓塞与肝素使用：在实际选择、医学协会建议及缺乏指南之间权衡
J Thromb Thrombolysis. 2020 Jul;50(1):68-71. doi: 10.1007/s11239-020-02125-4.
4
COVID-19 and SIC (!).2019冠状病毒病与噬血细胞性淋巴组织细胞增生症（！）
J Vasc Surg. 2020 Sep;72(3):1148-1150. doi: 10.1016/j.jvs.2020.05.047. Epub 2020 Jun 1.
5
COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.新型冠状病毒肺炎凝血功能障碍与炎症：已知与未知
Anesth Analg. 2020 Nov;131(5):1323. doi: 10.1213/ANE.0000000000005215.
6
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
7
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.抗凝治疗的重症 COVID-19 患者中静脉血栓栓塞事件发生率高。
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
8
Venous thromboembolism in non-critically ill patients with COVID-19 infection.COVID-19 感染非危重症患者的静脉血栓栓塞症。
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
9
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
10
Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.简要研究：新型冠状病毒肺炎中的凝血功能障碍：确定和管理新型冠状病毒肺炎感染中的血栓形成风险
Clin Med (Lond). 2020 Jul;20(4):e59. doi: 10.7861/clinmed.rib.20.4.2.
引用本文的文献
1
Lipoprotein(a): A New Intensive Care Unit Admission Predictor in Coronavirus Disease 2019 Patients.脂蛋白(a)：2019冠状病毒病患者入住重症监护病房的新预测指标
Thorac Res Pract. 2023 Jul;24(4):214-219. doi: 10.5152/ThoracResPract.2023.22065.
2
Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients.血浆内脂素作为新冠病毒肺炎患者血栓形成事件的生物标志物
J Clin Med. 2022 Sep 22;11(19):5560. doi: 10.3390/jcm11195560.
3
Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant.严重急性呼吸综合征冠状病毒 2 型β变体的免疫和病理学特征。
Microbiol Spectr. 2022 Oct 26;10(5):e0237122. doi: 10.1128/spectrum.02371-22. Epub 2022 Aug 25.
4
Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis.与非COVID-19队列相比，COVID-19患者的静脉血栓栓塞：一项系统评价与荟萃分析
J Clin Med. 2021 Oct 25;10(21):4925. doi: 10.3390/jcm10214925.
5
Can Serum Endocan Levels be Used as an Early Prognostic Marker for Endothelial Dysfunction in COVID-19?血清内皮细胞蛋白聚糖水平能否作为 COVID-19 内皮功能障碍的早期预后标志物？
Angiology. 2022 May;73(5):438-444. doi: 10.1177/00033197211050446. Epub 2021 Oct 18.
6
Thrombosis, an important piece in the COVID-19 puzzle: From pathophysiology to therapy.血栓形成，新冠疫情谜团中的重要一环：从病理生理学到治疗
Anatol J Cardiol. 2021 Sep;25(9):601-608. doi: 10.5152/AnatolJCardiol.2021.475.
7
Severe COVID-19: A distinct entity.重症新型冠状病毒肺炎：一种独特的疾病实体。
J Family Med Prim Care. 2021 Jan;10(1):84-92. doi: 10.4103/jfmpc.jfmpc_1600_20. Epub 2021 Jan 30.
8
Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions.2019冠状病毒病患者的止血变化：一项采用Meta回归的Meta分析
J Clin Med. 2020 Jul 15;9(7):2244. doi: 10.3390/jcm9072244.
本文引用的文献
1
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies.COVID-19 和静脉血栓栓塞症：文献研究的荟萃分析。
Semin Thromb Hemost. 2020 Oct;46(7):763-771. doi: 10.1055/s-0040-1715456. Epub 2020 Sep 3.
2
COVID-19 and functional disability: current insights and rehabilitation strategies.2019冠状病毒病与功能障碍：当前见解与康复策略
Postgrad Med J. 2021 Jul;97(1149):469-470. doi: 10.1136/postgradmedj-2020-138227. Epub 2020 Aug 4.
3
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
4
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.2019冠状病毒病患者的肺栓塞：对患病率增加的认识
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
5
Clinical characteristics of 3062 COVID-19 patients: A meta-analysis.3062 例 COVID-19 患者的临床特征：一项荟萃分析。
J Med Virol. 2020 Oct;92(10):1902-1914. doi: 10.1002/jmv.25884. Epub 2020 Jun 24.
6
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
7
Rehabilitation of COVID-19 patients.新型冠状病毒肺炎患者的康复治疗
J Rehabil Med. 2020 Apr 15;52(4):jrm00046. doi: 10.2340/16501977-2678.
8
Editorial: Covid-19 and Physical and Rehabilitation Medicine.社论：新冠疫情与物理医学与康复医学
J Rehabil Med. 2020 Apr 15;52(4):jrm00045. doi: 10.2340/16501977-2679.
9
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.在新型冠状病毒肺炎（COVID-19）的治疗中应注意静脉血栓栓塞的预防。
Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.
10
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
Zotero 插件